Announcements Trials

Browse Landscape

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 1 Breast Neoplasms 1 Advanced Breast Cancer 1

Interventions

Fulvestrant 6 olaparib 4 Letrozole 4 trastuzumab deruxtecan 3 Aromatase Inhibitors 3 Anastrozole 3 sacituzumab govitecan 2 pyrotinib 2 eribulin 2 dalpiciclib 2 Paclitaxel 2 Goserelin 2 Gonadotropin-Releasing Hormone 2 FCN-437c 2 Capecitabine 2 toripalimab 1 talazoparib 1 sonidegib 1 ribociclib 1 pembrolizumab 1 neratinib 1 liposomal doxorubicin 1 elacestrant 1 disitamab vedotin 1 ceralasertib 1 capivasertib 1 balixafortide 1 apatinib 1 abemaciclib 1 Vorinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Breast Cancer × Safety × Clear all

NCT06926088 2025-04-13

CAMELIA

The First Affiliated Hospital with Nanjing Medical University

Active not recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡